Macro&Micro- Test

Macro & Micro-Test owns molecular diagnosis, immunology, POCT and other technology platforms, with product lines covering infectious disease prevention and control, reproductive health testing, genetic disease testing, personalized drug gene testing, COVID-19 detection and other business fields. The company has successively undertaken quite a few significant projects such as the National Infectious Disease Project, the National High-Tech R&D Program (Program 863), the National Key Basic R&D Program (Program 973) and the National Natural Science Foundation of China. Moreover, close collaboration has been established with top scientific institutions in China.